carvedilol has been researched along with probucol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Morita, M; Naito, Y; Niki, E; Yoshikawa, T | 1 |
| Cheng, HY; Feuerstein, GZ; Gu, JL; Mckenna, PJ; Ruffolo, RR; Yue, TL | 1 |
| Fyhrquist, F; Metsärinne, K; Saijonmaa, O | 1 |
| Demura, H; Nomura, K; Ujihara, M; Yamada, O | 1 |
| Barberi, L; Catapano, AL; Donetti, E; Fumagalli, R; Paoletti, R; Roma, P; Soma, MR | 1 |
| Ahn, YK; Cha, KS; Cho, JG; Hong, YJ; Hur, SH; Hyun, DW; Jeong, MH; Kang, JC; Kim, JH; Kim, KB; Kim, MH; Kim, W; Park, HW; Park, JC; Park, JT | 1 |
| Chen, JW; Chen, YH; Chen, YL; Leu, HB; Lin, FY; Lin, SJ; Wu, TC | 1 |
9 other study(ies) available for carvedilol and probucol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of plasma lipid oxidation induced by peroxyl radicals, peroxynitrite, hypochlorite, 15-lipoxygenase, and singlet oxygen by clinical drugs.
Topics: Animals; Antioxidants; Antipyrine; Arachidonate 15-Lipoxygenase; Edaravone; Free Radicals; Hypochlorous Acid; Lipid Metabolism; Lipids; Mice; Oxidants; Oxidation-Reduction; Peroxides; Peroxynitrous Acid; Plasma; Probucol; Singlet Oxygen | 2016 |
Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Cattle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Free Radical Scavengers; Free Radicals; Glutathione; L-Lactate Dehydrogenase; Lipid Peroxidation; Nicardipine; Oxidation-Reduction; Probucol; Propanolamines; Reactive Oxygen Species | 1993 |
Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Ascorbic Acid; Calcium Channel Blockers; Carbazoles; Carvedilol; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Humans; Metoprolol; Nicardipine; Prazosin; Probucol; Propanolamines; Propranolol; Umbilical Veins | 1997 |
Establishment of a stable HL60 subline having the potential for monocytic differentiation using granulocyte-macrophage colony-stimulating factor: possible use for the study of monocytic differentiation and oxidative stress.
Topics: Calcitriol; Carbazoles; Carvedilol; Cell Differentiation; Free Radical Scavengers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Monocytes; Oxidative Stress; Probucol; Propanolamines; Superoxides; Tretinoin; Tumor Cells, Cultured | 1998 |
Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Anticholesteremic Agents; Antihypertensive Agents; Antioxidants; Aorta; Arteries; Arteriosclerosis; Carbazoles; Carotid Arteries; Carvedilol; Cell Division; Hypercholesterolemia; Male; Probucol; Propanolamines; Rabbits; Tunica Intima; Tunica Media | 1998 |
Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model.
Topics: Animals; Antioxidants; Carbazoles; Carvedilol; Coronary Restenosis; Disease Models, Animal; Probucol; Propanolamines; Swine | 2005 |
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Aorta, Abdominal; Atherosclerosis; Carbazoles; Carvedilol; Cells, Cultured; Deoxyguanosine; Diet, Atherogenic; Humans; Hyperplasia; Male; Matrix Metalloproteinase Inhibitors; Probucol; Propanolamines; Rabbits; RNA, Messenger; Tumor Necrosis Factor-alpha; Tunica Intima | 2007 |